OAK

Korean clinical practice guideline for the diagnosis and treatment of insomnia in adults

Metadata Downloads
Abstract
Objective We aim to present a clinical guideline for the diagnosis and treatment of insomnia in adults by reviewing and integrating ex-isting clinical guidelines. The purpose of this guideline is to assist clinicians who perform evidence-based insomnia treatment. Methods We selected literature that may be appropriate for use in guideline development from evidence-based practice guidelines that have been issued by an academic or governmental institution within the last five years. The core question of this guideline was made in sentence form including Patient/Problem, Intervention, Comparison, Outcome (PICO) elements. After searching PubMed, EMBASE, and medical guideline issuing agencies, three guidelines were judged to be the most appropriately reviewed, up-to-date, and from trust-ed sources. Results The Appraisal of Guidelines for Research and Evaluation (AGREE) II tool was used to evaluate the quality of the three clinical guidelines. The final outcome of the guideline development process is a total of 15 recommendations that report the strength of the rec-ommendation, the quality of evidence, a summary of content, and considerations in applying the recommendation. Conclusion It is vital for clinical guidelines for insomnia to be developed and continually updated in order to provide more accurate evidence-based treatments to patients. © 2020 Korean Neuropsychiatric Association.
Author(s)
Choi, H.Youn, S.Um, Y.H.Kim, T.W.Ju, G.Lee, H.J.Lee, C.Lee, S.D.Bae, K.Kim, S.J.Lee, J.H.Kim, T.Chung, S.
Issued Date
2020-11
Type
Article
DOI
10.30773/pi.2020.0146
URI
https://scholar.gist.ac.kr/handle/local/11861
Publisher
Korean Neuropsychiatric Association
Citation
Psychiatry Investigation, v.17, no.11, pp.1048 - 1059
ISSN
1738-3684
Appears in Collections:
Department of Biomedical Science and Engineering > 1. Journal Articles
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.